Telix Pharmaceuticals | TLX - Trade Creditors


Telix Pharmaceuticals reported AUD168.97M in Trade Creditors for its fiscal semester ending in June of 2026.





Trade Creditors Change Date
Cochlear AUD 281.3M 17.1M Dec/2025
CSL USD 3.17B 290M Dec/2025
Integral Diagnostics AUD 28.28M 17.87M Dec/2023
Mayne Pharma AUD 30.25M 2.99M Jun/2025
Medical Developments International AUD 4.31M 2.18M Dec/2025
Mesoblast USD 46.81M 13.23M Jun/2026
Neuren Pharmaceuticals AUD 2.4M 4.26M Dec/2025
Pacific Edge NZD 5.66M 212K Jun/2026
Paradigm Biopharmaceuticals AUD 4.44M 1.71M Dec/2025
Polynovo AUD 4.9M 2.04M Dec/2025
PYC Therapeutics AUD 9.56M 802.76K Dec/2025
Ramsay Health Care AUD 2.02B 289.9M Dec/2025
ResMed USD 273.3M 22.89M Mar/2026
Sonic Healthcare AUD 313.54M 543.93M Jun/2024